Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.03 (+3.43%)
As of: Oct 2, 2026 · 10:22 AM EDT

Rani Therapeutics Holdings (RANI) Shares Outstanding (Entity) (2020 - 2026)

Updated

Rani Therapeutics Holdings' Shares Outstanding (Entity) was 187.17 million in Q2 2026, up 196.1% from 63.21 million a year earlier and up 4.0% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at Rani Therapeutics Holdings came in at 121.59 million, up 111.8% from FY2024.

  • Shares Outstanding (Entity) has now increased for three consecutive years, with a four-year compound annual growth rate of 22.7% (FY2021 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 57.4 million in FY2024 (+14.5%), 50.15 million in FY2023 (+1.5%), 49.41 million in FY2022 (-7.9%) and 53.68 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2020.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 14 straight quarters, with growth averaging 76.9% over the last eight quarters.
  • The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q1 2026 (growth of 212.8%); the worst was Q4 2022 (a decline of 7.9%).
  • Per Business Quant data, RANI's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 180 million (Q1 2026), 121.59 million (Q4 2025) and 71.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 187.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.17 Mn
Mar 31, 2026 180.00 Mn
Dec 31, 2025 121.59 Mn
Sep 30, 2025 71.91 Mn
Jun 30, 2025 63.21 Mn
Mar 31, 2025 57.54 Mn
Dec 31, 2024 57.40 Mn
Sep 30, 2024 53.92 Mn
Jun 30, 2024 50.61 Mn
Mar 31, 2024 50.41 Mn
Dec 31, 2023 50.15 Mn
Sep 30, 2023 49.99 Mn
Jun 30, 2023 49.63 Mn
Mar 31, 2023 49.49 Mn
Dec 31, 2022 49.41 Mn
Sep 30, 2022 49.36 Mn
Jun 30, 2022 49.16 Mn
Mar 31, 2022 49.16 Mn
Dec 31, 2021 53.68 Mn
Sep 30, 2021 49.00 Mn
API Access

Rani Therapeutics Holdings Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RANI&period=max&api_key=YOUR_API_KEY